Cargando…

321. Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection

BACKGROUND: Optimal antibiotic therapy following surgery for prosthetic joint infection (PJI) depends on potency, toxicity, convenience, and cost. Daptomycin, a potent, convenient, and low-toxicity antibiotic, is FDA approved for the treatment of skin and soft-tissue infections, but its role in trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Andy, Russell, Celeste, Nocon, Allina, Westrich, Geoffrey, Brause, Barry, Henry, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254884/ http://dx.doi.org/10.1093/ofid/ofy210.332

Ejemplares similares

The Influence of Obesity on the Infection Risk of Prosthetic Joint Infection in the Geriatric Orthopedic Population
por: Nocon, Allina, et al.
Publicado: (2017)

Low Rate of Microbiologic Relapse in Two-Stage Exchange for Hip Prosthetic Joint Infections
por: Henry, Michael, et al.
Publicado: (2017)

311. Low Rate of Microbiologic Relapse in Two-Stage Exchange for Knee Prosthetic Joint Infections
por: Henry, Michael, et al.
Publicado: (2018)

Reexamining BSA as a Preoperative Predictor of Risk of Prosthetic Joint Infection
por: Russell, Celeste, et al.
Publicado: (2017)

Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection
por: Carli, Alberto V., et al.
Publicado: (2020)

309. The Infected Spacer: The Impact of Spacer Exchanges and Debridements on Two-Stage Exchange Arthroplasty Outcomes
por: Henry, Michael, et al.
Publicado: (2018)

Assessment of Musculoskeletal Infection Society (MSIS) Diagnostic Criteria as Predictors of Treatment Success in Hip Arthroplasty Infections Treated with Two-Stage Exchange
por: Henry, Michael, et al.
Publicado: (2017)

310. Assessment of MSIS Diagnostic Criteria as Predictors of Treatment Success in Total Knee Arthroplasty (TKA) Infections Treated With Two-Stage Exchange
por: Miller, Andy, et al.
Publicado: (2018)

383. Rheumatic Disease Patients Have More Culture Negative Prosthetic Joint Infections: Are There Clinical Differences?
por: Kapadia, Milan, et al.
Publicado: (2019)

382. Difference in Pathogens Between Hip and Knee Prosthetic Joint Infection
por: Henry, Michael, et al.
Publicado: (2019)

395. Safety and Tolerability of Rifampin in Staphylococcal Orthopedic Infections
por: Miller, Andy O, et al.
Publicado: (2019)

390. Treatment and Outcome of Methicillin-Resistant Staphylococcus aureus Hip and Knee Prosthetic Joint Infection
por: Henry, Michael, et al.
Publicado: (2019)

Clinical and Histological Features of Prosthetic Joint Infections May Differ in Patients With Inflammatory Arthritis and Osteoarthritis
por: Sculco, Peter, et al.
Publicado: (2023)

691 Rifampin in the Treatment of Staphylococcal Prosthetic Joint Infections
por: Parsaei, Shadi, et al.
Publicado: (2014)

Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection
por: Chang, Yu-Jui, et al.
Publicado: (2017)

1293. Efficacy of Doxycycline in Staphylococcal Prosthetic Joint Infection Treated with Debridement, Antibiotics and Implant Retention (DAIR) or Revision with Destination Spacer Placement
por: Jang, Timothy, et al.
Publicado: (2023)

399. Treatment and Outcome of Prosthetic Joint Infection in Unicompartmental Knee Arthroplasty
por: Carli, Alberto V, et al.
Publicado: (2019)

239. Sex Differences in Prosthetic Joint Infection
por: Mironenko, Christine M, et al.
Publicado: (2021)

1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia
por: Bouchard, Jeannette, et al.
Publicado: (2018)

1306. Lower Treatment Failure Rates in Patients with Non-Staphylococcal Prosthetic Joint Infections (PJI) Treated with Debridement and Implant Retention (DAIR) Receiving Chronic Antibiotic Suppression (CAS)
por: Sekar, Poorani, et al.
Publicado: (2023)

Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin
por: Kuo, Feng-Chih, et al.
Publicado: (2016)

Daptomycin versus Vancomycin as Post-Operative Empirical Antibiotic Treatment for Prosthetic Joint Infections: A Case-Control Study
por: Joseph, C, et al.
Publicado: (2019)

793. Rifabutin Use in Staphylococcal Prosthetic Material Infections: A Case Series
por: Monk, Miranda, et al.
Publicado: (2021)

177. Clinical Outcomes of Daptomycin vs. Anti-Staphylococcal β-Lactams in Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bloodstream Infections
por: Agnello, Sydney, et al.
Publicado: (2019)

Self-enhanced targeted delivery of a cell wall– and membrane-active antibiotics, daptomycin, against staphylococcal pneumonia
por: Jiang, Hong, et al.
Publicado: (2016)

Emergence of Daptomycin Resistance in Daptomycin-Naïve Rabbits with Methicillin-Resistant Staphylococcus aureus Prosthetic Joint Infection Is Associated with Resistance to Host Defense Cationic Peptides and mprF Polymorphisms
por: Mishra, Nagendra N., et al.
Publicado: (2013)

Use of Daptomycin for the Treatment of Methicillin-Resistant Coagulase-Negative Staphylococcal Ventriculitis
por: Erritouni, Mohamed, et al.
Publicado: (2012)

1210. Staphylococcal Acute Post-Operative Prosthetic Joint Infection (PJI) Treated With “DAIR” (Debridement and Implant Retention) and Impact of Rifampin: A Retrospective Cohort Study in France
por: Becker, Agathe, et al.
Publicado: (2018)

Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial
por: Karlsen, Øystein Espeland, et al.
Publicado: (2020)

596. Distinct, Segregated Daptomycin-Susceptible and Daptomycin-Nonsusceptible Staphylococcus aureus Populations Associated with Tricuspid-Valve Infective Endocarditis
por: Miller, Christopher R, et al.
Publicado: (2019)

381. Clinical Outcome of Polymicrobial Prosthetic Joint Infection Managed with Debridement, Antibiotics, and Implant Retention (DAIR)
por: Hooshmand, Babak, et al.
Publicado: (2019)

613. Suppression of Daptomycin Resistance Development in Staphylococcus aureus Is a Class Effect of β-Lactams and Is Independent of Daptomycin–β Lactam Synergy
por: Miller, Christopher R, et al.
Publicado: (2019)

290. Safety and Effectiveness of Oral Sodium Fusidate (Fusidic Acid) as Chronic Antibiotic Suppressive Therapy in Patients With Staphylococcal Bone or Joint Infections
por: Sheets, Amanda, et al.
Publicado: (2018)

320. Variation in Use of Chronic Antibiotic Suppression (CAS) for Treatment of Staphylococcus aureus Prosthetic Joint Infection (PJI)
por: Nair, Rajeshwari, et al.
Publicado: (2018)

315. Oral Vs. Intravenous Antibiotic Treatment for Gram-Positive Prosthetic Joint Infections: A Retrospective Study
por: Coehlo, Alexandre, et al.
Publicado: (2018)

1551. Systemic Tobramycin Absorption Resulting from Antibiotic-Impregnated Cement Spacers for the Treatment of Prosthetic Joint Infection
por: Como, James D, et al.
Publicado: (2019)

Cost-Savings Associated With Delayed Switch To Outpatient Antibiotic Regimen For Patients Requiring Daptomycin Therapy
por: Wei, Wenjing, et al.
Publicado: (2017)

1546. Efficacy of Daptomycin Combinations Against Daptomycin-Resistant Enterococcus faecium Differs by β-lactam
por: Kebriaei, Razieh, et al.
Publicado: (2019)

A FASII Inhibitor Prevents Staphylococcal Evasion of Daptomycin by Inhibiting Phospholipid Decoy Production
por: Pee, Carmen J. E., et al.
Publicado: (2019)

Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
por: Chang, Amy T, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t90qamsuglff1s99oqc6iin912